Role of EMT in CSC Plasticity

The epithelial-mesenchymal transition (EMT) is a process by which cancer stem cells (CSCs) acquire enhanced migratory and invasive properties, contributing to metastasis. This track explores the role of EMT in CSC plasticity and how it allows CSCs to switch between epithelial and mesenchymal states. Researchers investigate how EMT-related signaling pathways, such as TGF-β and ZEB1, regulate CSC behavior and promote tumor progression. Targeting EMT in CSCs could help prevent metastasis and improve treatment responses by limiting the cells’ ability to adapt and spread. This research aims to develop novel therapies that block EMT in CSCs, reducing their metastatic potential.

    Related Conference of Role of EMT in CSC Plasticity

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Role of EMT in CSC Plasticity Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in